359 related articles for article (PubMed ID: 15724952)
1. [Correlations between the hypothalamo-pituitary-adrenal axis and the metabolic syndrome].
Góth M; Hubina E; Korbonits M
Orv Hetil; 2005 Jan; 146(2):51-5. PubMed ID: 15724952
[TBL] [Abstract][Full Text] [Related]
2. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
Morton NM; Seckl JR
Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
[TBL] [Abstract][Full Text] [Related]
3. Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease.
Walker BR; Andrew R
Ann N Y Acad Sci; 2006 Nov; 1083():165-84. PubMed ID: 17148739
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
Stimson RH; Walker BR
Minerva Endocrinol; 2007 Sep; 32(3):141-59. PubMed ID: 17912154
[TBL] [Abstract][Full Text] [Related]
5. 11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice.
Harno E; Cottrell EC; Keevil BG; DeSchoolmeester J; Bohlooly-Y M; Andersén H; Turnbull AV; Leighton B; White A
Endocrinology; 2013 Oct; 154(10):3599-609. PubMed ID: 23832962
[TBL] [Abstract][Full Text] [Related]
6. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity.
Rask E; Walker BR; Söderberg S; Livingstone DE; Eliasson M; Johnson O; Andrew R; Olsson T
J Clin Endocrinol Metab; 2002 Jul; 87(7):3330-6. PubMed ID: 12107245
[TBL] [Abstract][Full Text] [Related]
7. Influence of the hypothalamic-pituitary-adrenal axis dysregulation on the metabolic profile of patients affected by diabetes mellitus-associated late onset hypogonadism.
Tirabassi G; Chelli FM; Ciommi M; Lenzi A; Balercia G
Nutr Metab Cardiovasc Dis; 2016 Jan; 26(1):53-9. PubMed ID: 26643209
[TBL] [Abstract][Full Text] [Related]
8. Prolonged hypothalamic-pituitary-adrenal axis activation after acute coronary syndrome in the GENESIS-PRAXY cohort.
Tang AR; Rabi DM; Lavoie KL; Bacon SL; Pilote L; Kline GA
Eur J Prev Cardiol; 2018 Jan; 25(1):65-72. PubMed ID: 28969495
[TBL] [Abstract][Full Text] [Related]
9. Sexual dimorphic evolution of metabolic programming in non-genetic non-alimentary mild metabolic syndrome model in mice depends on feed-back mechanisms integrity for pro-opiomelanocortin-derived endogenous substances.
Loizzo S; Vella S; Loizzo A; Fortuna A; Di Biase A; Salvati S; Frajese GV; Agrapart V; Ramirez Morales R; Spampinato S; Campana G; Capasso A; Galietta G; Guarino I; Carta S; Carru C; Zinellu A; Ghirlanda G; Seghieri G; Renzi P; Franconi F
Peptides; 2010 Aug; 31(8):1598-605. PubMed ID: 20493223
[TBL] [Abstract][Full Text] [Related]
10. Reduced 11beta-hydroxysteroid dehydrogenase type 1 activity in obese boys.
Wiegand S; Richardt A; Remer T; Wudy SA; Tomlinson JW; Hughes B; Grüters A; Stewart PM; Strasburger CJ; Quinkler M
Eur J Endocrinol; 2007 Sep; 157(3):319-24. PubMed ID: 17766714
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the role of cortisol and metabolic syndrome in age-related degenerative diseases.
Martocchia A; Stefanelli M; Falaschi GM; Toussan L; Ferri C; Falaschi P
Aging Clin Exp Res; 2016 Feb; 28(1):17-23. PubMed ID: 25813987
[TBL] [Abstract][Full Text] [Related]
12. Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma.
Fernández-Real JM; Engel WR; Simó R; Salinas I; Webb SM
Clin Endocrinol (Oxf); 1998 Jul; 49(1):53-61. PubMed ID: 9797847
[TBL] [Abstract][Full Text] [Related]
13. Activation of the hypothalamic-pituitary-adrenal axis in obesity: cause or consequence?
Walker BR
Growth Horm IGF Res; 2001 Jun; 11 Suppl A():S91-5. PubMed ID: 11527096
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid excess and the developmental origins of disease: two decades of testing the hypothesis--2012 Curt Richter Award Winner.
Reynolds RM
Psychoneuroendocrinology; 2013 Jan; 38(1):1-11. PubMed ID: 22998948
[TBL] [Abstract][Full Text] [Related]
15. Do alterations in placental 11beta-hydroxysteroid dehydrogenase (11betaHSD) activities explain differences in fetal hypothalamic-pituitary-adrenal (HPA) function following periconceptional undernutrition or twinning in sheep?
Connor KL; Challis JR; van Zijl P; Rumball CW; Alix S; Jaquiery AL; Oliver MH; Harding JE; Bloomfield FH
Reprod Sci; 2009 Dec; 16(12):1201-12. PubMed ID: 19767539
[TBL] [Abstract][Full Text] [Related]
16. Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor in the diet-induced obese mice.
Park JS; Rhee SD; Jung WH; Kang NS; Kim HY; Kang SK; Ahn JH; Kim KY
Eur J Pharmacol; 2012 Sep; 691(1-3):19-27. PubMed ID: 22760069
[TBL] [Abstract][Full Text] [Related]
17. Tissue-specific dysregulation of cortisol metabolism in human obesity.
Rask E; Olsson T; Söderberg S; Andrew R; Livingstone DE; Johnson O; Walker BR
J Clin Endocrinol Metab; 2001 Mar; 86(3):1418-21. PubMed ID: 11238541
[TBL] [Abstract][Full Text] [Related]
18. The effect of common genetic variation in 11β-hydroxysteroid dehydrogenase type 1 on hypothalamic-pituitary-adrenal axis activity and incident depression.
Dekker MJ; Tiemeier H; Luijendijk HJ; Kuningas M; Hofman A; de Jong FH; Stewart PM; Koper JW; Lamberts SW
J Clin Endocrinol Metab; 2012 Feb; 97(2):E233-7. PubMed ID: 22112815
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for the treatment of metabolic syndrome.
Wang M
Curr Opin Investig Drugs; 2006 Apr; 7(4):319-23. PubMed ID: 16625818
[TBL] [Abstract][Full Text] [Related]
20. [The metabolic syndrome as intrahepatocytic Cushing's syndrome].
Fernández Vázquez G; Torrecilla García E; Rubio Herrera MÁ
Endocrinol Nutr; 2011 Apr; 58(4):153-6. PubMed ID: 21371955
[No Abstract] [Full Text] [Related]
[Next] [New Search]
